CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
HT Meitei, N Jadhav, G Lal - Autoimmunity reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.
HT Meitei, N Jadhav, G Lal - Autoimmunity Reviews, 2021 - europepmc.org
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
[PDF][PDF] CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
HT Meitei, N Jadhav, G Lal - Autoimmunity reviews, 2021 - drive.google.com
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …